Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALMR

Alamar Biosciences Inc

Apr 30 • 11:22AM ET

24.69

+0.22 0.88 %

Healthcare • Medical Devices • USA • Small • NASD

Held by: ARKG LFSC

Index	-	P/E	-	EPS (ttm)	-	Insider Own	22.63%	Shs Outstand	66.52M	Perf Week	1.75%
Market Cap	1.66B	Forward P/E	-	EPS next Y	-	Insider Trans	3.20%	Shs Float	51.96M	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	12.25%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	27.20 -9.21%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	21.50 14.86%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.88% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	1.80%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	1.80%	Rel Volume	0.15	Prev Close	24.48
Employees	222	LT Debt/Eq	-	Earnings	-	SMA200	1.80%	Avg Volume	948.69K	Price	24.69
IPO	Apr 17, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	46,162	Change	0.88%

Apr-19-26 10:41PM

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

(PR Newswire)

Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Illumina Innovation Fund II GP	10% Owner	Apr 20 '26	Buy	17.00	235,294	3,999,998	507,076	Apr 20 08:45 PM
Naclerio Nicholas	Director	Apr 20 '26	Buy	17.00	235,294	3,999,998	507,076	Apr 20 08:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALMR

Alamar Biosciences Inc

Upgrade your Finviz experience